A University of Cincinnati study found administering an immunotherapy drug before surgery for oral cavity cancer did not lead to increased rates of complications during and after surgery.
This article was originally published on MedicalXpress.com
Pembrolizumab administration shown to not increase oral cavity surgery complications
You may also be interested in:
The Latest
Why you should stop buying vitamins and get more sleep instead
Almost half of all Canadians regularly take at least one nutritional supplement such as vitamins, minerals, fibre supplements, antacids and fish oils. Many of these individuals are healthy and hoping to improve general well-being or prevent chronic […]
The Latest
Best home maintenance tips and tricks that will save you time and money
Time….. Time is always the biggest factor when it comes to proper or terrible home maintenance. We have asked Toronto based home maintenance company, “what is the best way and what might be the worst property […]
The Latest
Will a nutritional supplement help you run better?
Whether you jog to keep fit or compete in marathons, the physically demanding sport of running can deplete the body of essential nutrients. During a race like a half-marathon, a runner’s metabolism — or ability […]
Read More:
-
A cap-and-invest strategy to cut transportation-related carbon emissions could provide substantial health benefits to children in New York City, with greater benefits among Black and [...]
-
Playgrounds are fun and can provide a great opportunity for exercise and family togetherness. But did you know that youths age 17 and younger are [...]
-
According to a new modeling study, published in JAMA Pediatrics, the number of children estimated to have experienced the death of a parent or caregiver [...]
